Compare MDXH & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MDXH | OXSQ |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 151.9M |
| IPO Year | 2021 | N/A |
| Metric | MDXH | OXSQ |
|---|---|---|
| Price | $2.30 | $1.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | 156.6K | ★ 1.3M |
| Earning Date | 05-13-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 24.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.78 | $3.61 |
| Revenue Next Year | $18.31 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.36 | $1.56 |
| 52 Week High | $5.33 | $2.64 |
| Indicator | MDXH | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 18.64 | 53.61 |
| Support Level | $1.90 | $1.68 |
| Resistance Level | $2.30 | $1.92 |
| Average True Range (ATR) | 0.20 | 0.05 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 3.45 | 75.00 |
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.